Rocket One Inc. (NasdaqCM: RKTO)
Health Care · Pharmaceuticals · US
$0.73
-2.70% today · -40.4% 1Y
Rocket One Inc. (NasdaqCM: RKTO) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $14.26M and employs 6 people.
Over the last twelve months the share price has lost 40.4%, trading between 0.49 and 2.45.
Tweenvest scores Rocket One Inc. across four factors: quality 26/100. Its strongest factor is quality.
RKTO price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $14.26M
- Revenue (TTM)
- —
- P/E
- —
- EPS
- -0.81
- Dividend yield
- —
- Beta (5Y)
- 0.96
- 52-week high
- $2.45
- 52-week low
- $0.49
- Avg volume (3M)
- —
- Shares outstanding
- 19.13M
- Employees
- 6
- Next earnings
- —
About Rocket One Inc.
Rocket One Inc. focuses on developing and commercializing AI semiconductor infrastructure. It also develops AI chip and memory hardware engineered for orbital and high-radiation environments, including next generation nanomagnetic AI chip technology. It offers semiconductor infrastructure built around nanomagnetic, and spintronic computing technologies designed to address these constraints at the hardware level. It also offers non-volatile nanomagnetic matrix multiplier architecture for machine learning and AI acceleration and spintronic memory technology with potential applications across defense systems, autonomous platforms, resilient edge compute, and radiation-tolerant space computing. The company was formerly known as Hoth Therapeutics, Inc. and changed its name to Rocket One Inc. in May 2026. The company was incorporated in 2017 and is based in Hoboken, New Jersey.
- ISIN
- US44148G2049
- Founded
- 2017
- Listed since
- Feb 15, 2019
- Exchange
- Nasdaq Capital Market
- Currency
- USD
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Eli Lilly and CompanyNYSE: LLY | $1.12T | $1,239.69 | -1.25% |
| Johnson & JohnsonNYSE: JNJ | $651.25B | $271.54 | +0.48% |
| Merck & Co., Inc.NYSE: MRK | $376.37B | $149.86 | -1.76% |
| Roche Holding AGSWX: ROP | $373.91B | CHF369.10 | -1.73% |
| Novartis AGSWX: NOVN | $302.17B | CHF127.42 | +0.85% |
| AstraZeneca PLCLSE: AZN | $258.76B | £120.32 | -1.70% |
| Novo Nordisk A/SCPSE: NOVO B | $207.84B | Dkr300.85 | +1.59% |
| Pfizer Inc.NYSE: PFE | $159.99B | $27.88 | -0.68% |
Figures last refreshed Aug 18, 2026.